Note:
Renal Dose Adjustment (Based on CrCl)
Hepatic Dose Adjustment
See Supplemental Patient Information
Cautions: Use cautiously in
Supplemental Patient Information
Pregnancy Category:B
Breastfeeding: Prolonged use or high doses of acrivastine may cause drowsiness and other effects in the infant or decrease the milk supply if used before lactation is well established or in combination with a sympathomimetic such as pseudoephedrine. Alternate nonsedating antihistamines are preferred. Small amounts of pseudoephedrine in breastmilk are unlikely to harm the nursing infant; however, it may cause irritability occasionally. A single dose of pseudoephedrine decreases milk production acutely and repeated use interferes with lactation. Mothers with newborns whose lactation is not well established or mothers who are having difficulties producing sufficient milk should not receive pseudoephedrine. This information is based upon Lactmed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 20 June 2011). Manufacturer recommends use in nursing mothers only when the potential benefit justifies the potential risks to the nursing infant.
Acrivastine
Pseudoephedrine
US Trade Name(s)
US Availability
Semprex-D (acrivastine/pseudoephedrine)
Canadian Trade Name(s)
Canadian Availability
UK Trade Name(s)
UK Availability
Benadryl Plus Capsules (acrivastine/pseudoephedrine)
Australian Trade Name(s)
Australian Availability
ENT
Nasal PreparationsAntihistamines & Decongestants
Allergy & Immunology
Nasal PreparationsAntihistamines & Decongestants
Pricing data from www.DrugStore.com in U.S.A.
Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.
Drug Name: Semprex-D (acrivastine 8 MG / pseudophedrine 60 MG) Oral Capsule
Ingredient(s): Acrivastine mixture with Pseudoephedrine
Imprint: 404;SEMPREX-D
Color(s): Green, White
Shape: Capsule
Size (mm): 16.00
Score: 1
Inactive Ingredient(s): lactose / magnesium stearate / sodium starch glycolate / gelatin / d&c yellow no. 10 / fd&c green no. 3 / titanium dioxide
Drug Label Author:
UCB, Inc.
DEA Schedule:
Non-Scheduled